ASND
Ascendis Pharma A/S
NASDAQ · Healthcare · Biotechnology · DK
$270.56
−0.21%Leverage
- Debt / equity
- 0.31x
- Net debt / equity
- -0.25x
- Debt / assets
- 0.20x
- Debt / EBITDA
- 5.76x
- Net debt / EBITDA
- -4.63x
Liquidity & coverage
- Current ratio
- 2.99x
- Quick ratio
- 2.32x
- Cash ratio
- 1.75x
- Interest coverage
- 0.67x
- EBITDA / interest
- 0.48x
- Working capital
- $1.1B
Cash & dividend
- FCF / debt
- 0.75x
- Cash flow / debt
- 0.78x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026